HIV/AIDS Clinical Trial
Official title:
Prevalence,Knowledge and Attitude of HIV /AIDS in Luxor
Human immunodeficiency virus infection is a global pandemic problem. About 35.3 million
infected people in the world, so causing a great social, economical, political and cultural
problems worldwide.
In 1986 Egypt's first AIDS case was discovered , since then the number of infected cases
cases are increasing.According to United Nations 2016 statistics, there are about 11,000
infected people living with Human immunodeficiency virus in Egypt.
Human immunodeficiency virus is a lentivirus that causes the infection and over time leading
to Acquired immunodeficiency syndrome.
The virus spread primarily by unprotected sex including vaginal, anal and oral sex,
contaminated blood transfusions, infected needles, and from mother to child during pregnancy,
delivery, or from milk during breastfeeding.
In 1986 Egypt's first AIDS case was discovered , since then the number of infected cases
cases are increasing.According to United Nations 2016 statistics, there are about 11,000
infected people living with Human immunodeficiency virus in Egypt.
According to the National Aids Program, the primary mode of transmission is heterosexual
intercourse, followed by homosexual intercourse , renal dialysis , and blood transfusion
Others include street children, prisoners, and refugees, female sex workers, men have sex
with men, and injecting drug users.
Human immunodeficiency virus related stigma and discrimination is a great barrier to
effectively fighting the disease epidemic.
This study will assess prevalence, knowledge, attitudes of Human immunodeficiency virus and
Acquired immunodeficiency syndrome people in Luxor Governorate in Upper Egypt.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
| Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
| Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
| Completed |
NCT04121962 -
A Pilot Peer Mentor Intervention That Trains Black Men Who Have Sex With Men (BMSM) to Use and Promote Uptake of HIV/STI Self-Testing to Peers and Sex Partners: STAR Study (Self-Testing at Your Residence)
|
N/A | |
| Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
| Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
| Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
| Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
| Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
| Not yet recruiting |
NCT05813964 -
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
|
Phase 3 | |
| Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
| Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
| Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
| Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
| Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
| Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
| Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
| Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A |